Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat vs recombinant human erythropoietin for chemotherapy-induced anemia in non-myeloid malignancies (Phase III, China)
CTR20213265Phase 3Completed
- Sponsor
- FibroGen
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of roxadustat in chemotherapy-induced anaemia (CIA), sponsored by FibroGen. Started Dec 2021; status: completed.
02
Drugs
roxadustat
03
Conditions
chemotherapy-induced anaemia (CIA)
Beyond the preview
Go deeper on CTR20213265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20213265.